Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 70 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Margriet P.

Netherlands

USD 70 /hr

Expert in human health risk assessment of nanotechnology and medical technology

Profile Summary

My name is Margriet Park. I have a Master's in Biology and a PhD in nanotoxicology. I have over 15 years of experience in conducting research and publishing manuscripts on exposure assessment, toxicity and human health risks of chemical substances, pharmaceuticals and nanomaterials. In addition, I have contributed to various national and international projects on medical technology, such as stem cell technology and regenerative medicine. Contact me if you need help on writing or reviewing project proposals, designing experiments, data analysis, or writing/editing your manuscript or report.

Subject Matter Expertise

• ☆ Nanotechnology & Nanomaterials
• ☆ Medical Sciences

Services

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Work Experience

senior researcher

National Institute for Public Health and the Environment (RIVM)

October 2004 - Present

Rijksinstituut voor Volksgezondheid en Milieu

2004 - Present

Toxicologist

Loders Croklaan Lipid Nutrition

February 2003 - September 2004

Research assistant

Michigan State University

September 2001 - October 2002

Education

PhD in Nanotoxicology

Maastricht University

October 2007 - July 2011

PhD (Toxicogenomics)

Maastricht University

2007 - 2011

MSc Biology (Toxicology)

Wageningen Universiteit en Researchcentrum

1996 - 2001

International Baccalaureate

United World College of the Atlantic

September 1992 - June 1994

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

(2019). Systematic selection of a dose metric for metal-based nanoparticles . NanoImpact. 13. p. 70-75.

(2019). Sensitive method for endotoxin determination in nanomedicinal product samples . Nanomedicine. 14. (10). p. 1231-1246.

(2019). Assessment of oxidative damage induced by iron oxide nanoparticles on different nervous system cells . Mutation Research - Genetic Toxicology and Environmental Mutagenesis. 845.

Halamoda-Kenzaoui, B., Baconnier, S., Bastogne, T., Bazile, D., Boisseau, P., Borchard, G., Borgos, S.E., Calzolai, L., Cederbrant, K., Di Felice, G., et al.(2019). Bridging communities in the field of nanomedicine . Regulatory Toxicology and Pharmacology. 106. p. 187-196.

(2018). Development of a systematic method to assess similarity between nanomaterials for human hazard evaluation purposes–lessons learnt . Nanotoxicology. 12. (7). p. 652-676.

(2018). Quality evaluation of human and environmental toxicity studies performed with nanomaterials-the GUIDEnano approach . Environmental Science: Nano. 5. (2). p. 381-397.

(2017). Considerations for Safe Innovation: The Case of Graphene . ACS nano.

(2017). Nanomedicinal products: A survey on specific toxicity and side effects . International Journal of Nanomedicine. 12. p. 6107-6129.

Park, M.V.D.Z., Bleeker, E.A.J., Brand, W., Cassee, F.R., Van Elk, M., Park, M.V.D.Z., Bleeker, E.A.J., Brand, W., Cassee, F.R., Van Elk, M., et al.(2017). Considerations for Safe Innovation: The Case of Graphene . ACS Nano. 11. (10). p. 9574-9593.

(2016). Simple in vitro models can predict pulmonary toxicity of silver nanoparticles . Nanotoxicology. 10. (6). p. 770-779.

(2016). A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements . International Journal of Nanomedicine. 11. p. 2935-2952.

(2015). Progress and future of in vitro models to study translocation of nanoparticles . Archives of Toxicology. 89. (9). p. 1469-1495.

Hougaard, K.S., Campagnolo, L., Chavatte-Palmer, P., Hougaard, K.S., Hougaard, K.S., Campagnolo, L., Chavatte-Palmer, P., Tarrade, A., Rousseau-Ralliard, D., Valentino, S., et al.(2015). A perspective on the developmental toxicity of inhaled nanoparticles . Reproductive Toxicology. 56. p. 118-140.

(2015). A practical approach to determine dose metrics for nanomaterials . Environmental Toxicology and Chemistry. 34. (5). p. 1015-1022.

(2014). Physicochemical characteristics of nanomaterials that affect pulmonary inflammation . Particle and Fibre Toxicology. 11. (1).

(2014). Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles . Particle and Fibre Toxicology. 11. (1).

(2013). Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats . Biomaterials. 34. (33). p. 8333-8343.

Park, M.V.D.Z., Verharen, H.W., Zwart, E., Hernandez, L.G., Van Benthem, J., Elsaesser, A., Barnes, C., McKerr, G., Howard, C.V., Salvati, A., et al.(2011). Genotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay . Nanotoxicology. 5. (2). p. 168-181.

(2009). In vitro developmental toxicity test detects inhibition of stem cell differentiation by silica nanoparticles . Toxicology and Applied Pharmacology. 240. (1). p. 108-116.

(2009). The status of in vitro toxicity studies in the risk assessment of nanomaterials . Nanomedicine. 4. (6). p. 669-685.

BOOK

Colognato, R., Park, M.V.D.Z., Wick, P., De Jong, W.H.(2012). Interactions with the Human Body . Adverse Effects of Engineered Nanomaterials. p. 3-24.